cyclo(alanylalanyl) has been researched along with nu 1025 in 1 studies
Studies (cyclo(alanylalanyl)) | Trials (cyclo(alanylalanyl)) | Recent Studies (post-2010) (cyclo(alanylalanyl)) | Studies (nu 1025) | Trials (nu 1025) | Recent Studies (post-2010) (nu 1025) |
---|---|---|---|---|---|
5 | 0 | 3 | 39 | 0 | 17 |
Protein | Taxonomy | cyclo(alanylalanyl) (IC50) | nu 1025 (IC50) |
---|---|---|---|
Chain A, Poly(adp-ribose) Polymerase | Gallus gallus (chicken) | 0.4 | |
Chain A, Poly(adp-ribose) Polymerase | Gallus gallus (chicken) | 0.4 | |
Chain A, Poly(adp-ribose) Polymerase | Gallus gallus (chicken) | 0.4 | |
Poly [ADP-ribose] polymerase 1 | Mus musculus (house mouse) | 0.4 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jain, PG; Patel, BD | 1 |
1 review(s) available for cyclo(alanylalanyl) and nu 1025
Article | Year |
---|---|
Medicinal chemistry approaches of poly ADP-Ribose polymerase 1 (PARP1) inhibitors as anticancer agents - A recent update.
Topics: Animals; Antineoplastic Agents; Chemistry, Pharmaceutical; Humans; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Structure-Activity Relationship | 2019 |